Related Experiment Video
Updated: Apr 25, 2026
07:51
Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
Published on: February 1, 2022
2.9K
3D label-free prostate specific antigen (PSA) immunosensor based on graphene-gold composites
Hee Dong Jang1, Sun Kyung Kim2, Hankwon Chang1
1Rare Metals Research Center, Korea Institute of Geoscience and Mineral Resources, Daejeon 305-350, Korea.
Biosensors & Bioelectronics
|August 25, 2014
Summary
A new 3D electrochemical immunosensor offers highly sensitive, label-free detection of prostate specific antigen (PSA). This advancement improves early prostate cancer diagnosis by providing a low detection limit and enhanced sensitivity.
Area of Science:
- Biomedical Engineering
- Electrochemistry
- Nanotechnology
Background:
- Accurate and sensitive detection of prostate specific antigen (PSA) is crucial for early prostate cancer diagnosis.
- Existing methods for PSA detection face challenges in sensitivity and label-free capabilities.
- Developing novel electrochemical immunosensors is key to overcoming these diagnostic limitations.
Purpose of the Study:
- To develop a novel three-dimensional (3D) electrochemical immunosensor for highly sensitive and label-free detection of PSA.
- To investigate the performance of a graphene (GR)-based gold (Au) composite modified electrode for PSA detection.
- To establish a new diagnostic tool for prostate cancer with improved sensitivity and a low detection limit.
Main Methods:
- Fabrication of a 3D electrode using aerosol spray pyrolysis to create a crumpled graphene ball decorated with gold nanoparticles.
- Modification of the electrode surface with the GR-Au composite for enhanced conductivity and surface area.
- Electrochemical analysis for label-free detection and quantification of PSA within a specific concentration range.
Main Results:
- The 3D electrochemical immunosensor demonstrated high sensitivity and label-free detection of PSA.
- A broad linear detection range of 0-10 ng/mL was achieved for PSA.
- A low limit of detection (LOD) of 0.59 ng/mL was obtained, indicating significant improvement over existing methods.
- The immunosensor exhibited a high current change rate of 5 μA/(ng/mL) with respect to PSA concentration.
- Excellent selectivity, reproducibility, and stability were observed for the developed immunosensor.
Conclusions:
- The novel 3D electrochemical immunosensor based on a GR-Au composite electrode provides a promising platform for sensitive and label-free PSA detection.
- This technology has the potential to significantly improve the early diagnosis of prostate cancer.
- The enhanced electron transfer and high sensitivity of the immunosensor represent a significant advancement in biosensing for cancer biomarkers.
